🔎 Trials Near Me

Hem › Sickelcellssjukdom › Florida

Kliniska studier för Sickelcellssjukdom i Florida

9 studier för Sickelcellssjukdom söker deltagare vid platser i Florida.

Städer i Florida

Officiell studietext (engelska)

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Memorial Healthcare, Hollywood
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT06612268

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  • Edward Jenner Research Group LLC., Plantation
  • Pediatric Hematology / Oncology a division of Kidz Medical services, West Palm Beach
  • St. Mary's Medical Center, West Palm Beach
RekryterarFas 2/3
Ålder 12 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • University of Florida Hemophilia Treatment Center, Gainesville
  • University of Miami Comprehensive Hemophilia Treatment Center, Miami
  • University of Miami Hospital and Clinics, Miami
  • och 4 fler
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 17 aug. 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • Golisano Children's Hospital, Fort Myers
  • The Foundation for Sickle Cell Disease, Hollywood
RekryterarFas 2
Ålder 12 och äldre · Alla kön · Uppdaterad 14 aug. 2026 · NCT06699849

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • The Foundation for Sickle Cell Disease, Hollywood
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT07224360

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  • Oncology & Hematology Associates of West Broward- Site Number : 8400029, Coral Springs
  • Sylvester Comprehensive Cancer Center- Site Number : 8400020, Miami
RekryterarFas 3
Ålder 10 till 65 · Alla kön · Uppdaterad 29 juli 2026 · NCT06975865

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

  • University of Florida, Gainesville
RekryterarFas 2
6 Months – 21 Years · Alla kön · Uppdaterad 27 juli 2026 · NCT02675959

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • Mayo Clinic Florida, Jacksonville
RekryterarObservationsstudie
Ålder 14 till 37 · Alla kön · Uppdaterad 28 jan. 2026 · NCT07373639

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.